
Where MedTech professionals gain clarity and confidence to navigate complex risk, quality, and leadership challenges.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 587 | Founded | 4 years ago | Last Issue | 6 days ago |
| Active | |||||

In responding to Comment #37 in the preamble of the QMSR1, FDA addresses a request to define labeling and marketing within the regulation.
FDA declined. “Label” and “labeling” are already defined in the FD&C Act, while marketing is not spe...
Dear colleagues:
Design FMEA and Process FMEA are different analyses, usually performed by different teams for different purposes.
But they should not tell disconnected risk stories.
A design failure mode may be controlled by a specifica...
PCCPs can turn regulatory cycle time into a competitive advantage, but only if the evidence needed to support future change is funded in advance.
Predetermined Change Control Plans (PCCP) are often discussed as a regulatory mechanism for m...
In responding to Comment #36 in the preamble of the QMSR1, FDA addresses differences in how ISO 13485 and FDA regulations use the term distributor.
For QMSR purposes, FDA relies on the ISO 13485 framework and emphasizes that the quality ma...
Dear colleagues:
Most organizations would say their supplier audit program is risk-based.
And in many cases, it is.
Suppliers may be classified by criticality, performance history, previous audit findings, CAPAs, or other factors, and th...
Subscribers, engagement, traffic and sponsorship for Let's Talk Risk!.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #184 |
The writers behind this newsletter.
MedTech risk management advisor, educator, and creator of Let’s Talk Risk! Sharing ideas on risk, quality, leadership, and decision-making under uncertainty.
You can find recent issues that have been published by Let's Talk Risk! on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Let's Talk Risk!, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Let's Talk Risk! as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Let's Talk Risk! using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Let's Talk Risk!. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.